Skip to main content
Top
Published in: Virology Journal 1/2012

Open Access 01-12-2012 | Methodology

A sensitive and specific blocking ELISA for the detection of rabbit calicivirus RCV-A1 antibodies

Authors: June Liu, Peter J Kerr, Tanja Strive

Published in: Virology Journal | Issue 1/2012

Login to get access

Abstract

Background

Antibodies to non-pathogenic rabbit caliciviruses (RCVs) cross-react in serological tests for rabbit hemorrhagic disease virus (RHDV) and vice versa, making epidemiological studies very difficult where both viruses occur. It is important to understand the distribution and interaction of the two viruses because the highly pathogenic RHDV has been used as a biocontrol agent for wild rabbits in Australia and New Zealand for the past 17 years. The presence of the benign RCV Australia 1 (RCV-A1) is considered a key factor for the failure of RHDV mediated rabbit control in cooler, wetter areas of Australia.

Results

A highly sensitive and specific blocking ELISA was developed for the detection of RCV-A1 antibodies. When sera from rabbits with a known infection history for either RCV-A1 or RHDV were tested, this assay showed 100% sensitivity and no cross-reactivity with RHDV sera (100% specificity).

Conclusions

This new ELISA not only allows the detection of RCV-A1 at a population level, but also permits the serological status of individual rabbits to be determined more reliably than previously described methods. This robust and simple to perform assay is therefore the tool of choice for studying RCV-A1 epidemiology in Australian wild rabbit populations.
Appendix
Available only for authorised users
Literature
1.
go back to reference Green KY, Ando T, Balayan MS, Berke T, Clarke IN, Estes MK, Matson DO, Nakata S, Neill JD, Studdert MJ, Thiel HJ: Taxonomy of the caliciviruses. J Infect Dis. 2000, 181 (Suppl 2): S322-330.PubMedCrossRef Green KY, Ando T, Balayan MS, Berke T, Clarke IN, Estes MK, Matson DO, Nakata S, Neill JD, Studdert MJ, Thiel HJ: Taxonomy of the caliciviruses. J Infect Dis. 2000, 181 (Suppl 2): S322-330.PubMedCrossRef
2.
go back to reference Capucci L, Nardin A, Lavazza A: Seroconversion in an industrial unit of rabbits infected with a non-pathogenic rabbit haemorrhagic disease-like virus. Vet Rec. 1997, 140: 647-650. 10.1136/vr.140.25.647.PubMedCrossRef Capucci L, Nardin A, Lavazza A: Seroconversion in an industrial unit of rabbits infected with a non-pathogenic rabbit haemorrhagic disease-like virus. Vet Rec. 1997, 140: 647-650. 10.1136/vr.140.25.647.PubMedCrossRef
3.
go back to reference Ohlinger VF, Haas B, Meyers G, Weiland F, Thiel HJ: Identification and characterization of the virus causing rabbit hemorrhagic disease. J Virol. 1990, 64: 3331-3336.PubMedPubMedCentral Ohlinger VF, Haas B, Meyers G, Weiland F, Thiel HJ: Identification and characterization of the virus causing rabbit hemorrhagic disease. J Virol. 1990, 64: 3331-3336.PubMedPubMedCentral
4.
go back to reference Parra F, Prieto M: Purification and characterization of a calicivirus as the causative agent of a lethal hemorrhagic disease in rabbits. J Virol. 1990, 64: 4013-4015.PubMedPubMedCentral Parra F, Prieto M: Purification and characterization of a calicivirus as the causative agent of a lethal hemorrhagic disease in rabbits. J Virol. 1990, 64: 4013-4015.PubMedPubMedCentral
5.
go back to reference Bruce JS, Twigg LE: Rabbit haemorrhagic disease virus: serological evidence of a non-virulent RHDV-like virus in south-western Australia. Wildl Res. 2004, 31: 605-612. 10.1071/WR04009.CrossRef Bruce JS, Twigg LE: Rabbit haemorrhagic disease virus: serological evidence of a non-virulent RHDV-like virus in south-western Australia. Wildl Res. 2004, 31: 605-612. 10.1071/WR04009.CrossRef
6.
go back to reference Cooke BD, McPhee S, Robinson AJ, Capucci L: Rabbit haemorrhagic disease: does a pre-existing RHDV-like virus reduce the effectiveness of RHD as a biological control in Australia?. Wildl Res. 2002, 29: 673-682. 10.1071/WR00092.CrossRef Cooke BD, McPhee S, Robinson AJ, Capucci L: Rabbit haemorrhagic disease: does a pre-existing RHDV-like virus reduce the effectiveness of RHD as a biological control in Australia?. Wildl Res. 2002, 29: 673-682. 10.1071/WR00092.CrossRef
7.
go back to reference Cooke BD, Robinson AJ, Merchant JC, Nardin A, Capucci L: Use of ELISAs in field studies of rabbit haemorrhagic disease (RHD) in Australia. Epidemiol Infect. 2000, 124: 563-576. 10.1017/S0950268899003994.PubMedPubMedCentralCrossRef Cooke BD, Robinson AJ, Merchant JC, Nardin A, Capucci L: Use of ELISAs in field studies of rabbit haemorrhagic disease (RHD) in Australia. Epidemiol Infect. 2000, 124: 563-576. 10.1017/S0950268899003994.PubMedPubMedCentralCrossRef
8.
go back to reference McPhee SR, Butler KL, Kovaliski J, Mutze G, Capucci L, Cooke BD: Antibody status and survival of Australian wild rabbits challenged with rabbit haemorrhagic disease virus. Wildl Res. 2009, 36: 447-456. 10.1071/WR08137.CrossRef McPhee SR, Butler KL, Kovaliski J, Mutze G, Capucci L, Cooke BD: Antibody status and survival of Australian wild rabbits challenged with rabbit haemorrhagic disease virus. Wildl Res. 2009, 36: 447-456. 10.1071/WR08137.CrossRef
9.
go back to reference Mutze G, Kovaliski J, Butler K, Capucci L, McPhee S: The effect of rabbit population control programmes on the impact of rabbit haemorrhagic disease in south-eastern Australia. J Appl Ecol. 2010, 47: 1137-1146. 10.1111/j.1365-2664.2010.01844.x.CrossRef Mutze G, Kovaliski J, Butler K, Capucci L, McPhee S: The effect of rabbit population control programmes on the impact of rabbit haemorrhagic disease in south-eastern Australia. J Appl Ecol. 2010, 47: 1137-1146. 10.1111/j.1365-2664.2010.01844.x.CrossRef
10.
go back to reference Mutze G, Sinclair R, Peacock D, Kovaliski J, Capucci L: Does a benign calicivirus reduce the effectiveness of rabbit haemorrhagic disease virus (RHDV) in Australia? Experimental evidence from field releases of RHDV on bait. Wildl Res. 2010, 37: 311-319. 10.1071/WR09162.CrossRef Mutze G, Sinclair R, Peacock D, Kovaliski J, Capucci L: Does a benign calicivirus reduce the effectiveness of rabbit haemorrhagic disease virus (RHDV) in Australia? Experimental evidence from field releases of RHDV on bait. Wildl Res. 2010, 37: 311-319. 10.1071/WR09162.CrossRef
11.
go back to reference Robinson AJ, Kirkland PD, Forrester RI, Capucci L, Cooke BD, Philbey AW: Serological evidence for the presence of a calicivirus in Australian wild rabbits, Oryctolagus cuniculus, before the introduction of rabbit haemorrhagic disease virus (RHDV): its potential influence on the specificity of a competitive ELISA for RHDV. Wildl Res. 2002, 29: 655-662. 10.1071/WR00096.CrossRef Robinson AJ, Kirkland PD, Forrester RI, Capucci L, Cooke BD, Philbey AW: Serological evidence for the presence of a calicivirus in Australian wild rabbits, Oryctolagus cuniculus, before the introduction of rabbit haemorrhagic disease virus (RHDV): its potential influence on the specificity of a competitive ELISA for RHDV. Wildl Res. 2002, 29: 655-662. 10.1071/WR00096.CrossRef
12.
go back to reference Mutze G, Cooke B, Alexander P: The initial impact of rabbit hemorrhagic disease on European rabbit populations in South Australia. J Wildl Dis. 1998, 34: 221-227.PubMedCrossRef Mutze G, Cooke B, Alexander P: The initial impact of rabbit hemorrhagic disease on European rabbit populations in South Australia. J Wildl Dis. 1998, 34: 221-227.PubMedCrossRef
13.
go back to reference Jahnke M, Holmes EC, Kerr PJ, Wright JD, Strive T: Evolution and phylogeography of the nonpathogenic calicivirus RCV-A1 in wild rabbits in Australia. J Virol. 2010, 84: 12397-12404. 10.1128/JVI.00777-10.PubMedPubMedCentralCrossRef Jahnke M, Holmes EC, Kerr PJ, Wright JD, Strive T: Evolution and phylogeography of the nonpathogenic calicivirus RCV-A1 in wild rabbits in Australia. J Virol. 2010, 84: 12397-12404. 10.1128/JVI.00777-10.PubMedPubMedCentralCrossRef
14.
go back to reference Strive T, Wright JD, Robinson AJ: Identification and partial characterisation of a new Lagovirus in Australian wild rabbits. Virology. 2009, 384: 97-105. 10.1016/j.virol.2008.11.004.PubMedCrossRef Strive T, Wright JD, Robinson AJ: Identification and partial characterisation of a new Lagovirus in Australian wild rabbits. Virology. 2009, 384: 97-105. 10.1016/j.virol.2008.11.004.PubMedCrossRef
15.
go back to reference Strive T, Wright J, Kovaliski J, Botti G, Capucci L: The non-pathogenic Australian lagovirus RCV-A1 causes a prolonged infection and elicits partial cross-protection to rabbit haemorrhagic disease virus. Virology. 2010, 398: 125-134. 10.1016/j.virol.2009.11.045.PubMedCrossRef Strive T, Wright J, Kovaliski J, Botti G, Capucci L: The non-pathogenic Australian lagovirus RCV-A1 causes a prolonged infection and elicits partial cross-protection to rabbit haemorrhagic disease virus. Virology. 2010, 398: 125-134. 10.1016/j.virol.2009.11.045.PubMedCrossRef
16.
go back to reference Delibes-Mateos M, Delibes M, Ferreras P, Villafuerte R: Key role of European rabbits in the conservation of the Western Mediterranean basin hotspot. Conserv Biol. 2008, 22: 1106-1117. 10.1111/j.1523-1739.2008.00993.x.PubMedCrossRef Delibes-Mateos M, Delibes M, Ferreras P, Villafuerte R: Key role of European rabbits in the conservation of the Western Mediterranean basin hotspot. Conserv Biol. 2008, 22: 1106-1117. 10.1111/j.1523-1739.2008.00993.x.PubMedCrossRef
17.
go back to reference Chen R, Neill JD, Estes MK, Prasad BV: X-ray structure of a native calicivirus: structural insights into antigenic diversity and host specificity. Proc Natl Acad Sci U S A. 2006, 103: 8048-8053. 10.1073/pnas.0600421103.PubMedPubMedCentralCrossRef Chen R, Neill JD, Estes MK, Prasad BV: X-ray structure of a native calicivirus: structural insights into antigenic diversity and host specificity. Proc Natl Acad Sci U S A. 2006, 103: 8048-8053. 10.1073/pnas.0600421103.PubMedPubMedCentralCrossRef
18.
go back to reference Forrester NL, Trout RC, Gould EA: Benign circulation of rabbit haemorrhagic disease virus on Lambay Island, Eire. Virology. 2007, 358: 18-22. 10.1016/j.virol.2006.09.011.PubMedCrossRef Forrester NL, Trout RC, Gould EA: Benign circulation of rabbit haemorrhagic disease virus on Lambay Island, Eire. Virology. 2007, 358: 18-22. 10.1016/j.virol.2006.09.011.PubMedCrossRef
19.
go back to reference Capucci L, Fusi P, Lavazza A, Pacciarini ML, Rossi C: Detection and preliminary characterisation of a new calicivirus related to rabbit haemorrhagic disease but non-pathogenic. J Virol. 1996, 70: 8614-8623.PubMedPubMedCentral Capucci L, Fusi P, Lavazza A, Pacciarini ML, Rossi C: Detection and preliminary characterisation of a new calicivirus related to rabbit haemorrhagic disease but non-pathogenic. J Virol. 1996, 70: 8614-8623.PubMedPubMedCentral
20.
go back to reference Le Gall-Recule G, Zwingelstein F, Fages MP, Bertagnoli S, Gelfi J, Aubineau J, Roobrouck A, Botti G, Lavazza A, Marchandeau S: Characterisation of a non-pathogenic and non-protective infectious rabbit lagovirus related to RHDV. Virology. 2010, 410: 395-402.PubMedCrossRef Le Gall-Recule G, Zwingelstein F, Fages MP, Bertagnoli S, Gelfi J, Aubineau J, Roobrouck A, Botti G, Lavazza A, Marchandeau S: Characterisation of a non-pathogenic and non-protective infectious rabbit lagovirus related to RHDV. Virology. 2010, 410: 395-402.PubMedCrossRef
21.
go back to reference Forrester NL, Boag B, Buckley A, Moureau G, Gould EA: Co-circulation of widely disparate strains of rabbit haemorrhagic disease virus could explain localised epidemicity in the United Kingdom. Virology. 2009, 393: 42-48. 10.1016/j.virol.2009.07.008.PubMedCrossRef Forrester NL, Boag B, Buckley A, Moureau G, Gould EA: Co-circulation of widely disparate strains of rabbit haemorrhagic disease virus could explain localised epidemicity in the United Kingdom. Virology. 2009, 393: 42-48. 10.1016/j.virol.2009.07.008.PubMedCrossRef
22.
go back to reference Cooke BD: Rabbit haemorrhagic disease: field epidemiology and the management of wild rabbit populations. Rev Sci Tech. 2002, 21: 347-358.PubMed Cooke BD: Rabbit haemorrhagic disease: field epidemiology and the management of wild rabbit populations. Rev Sci Tech. 2002, 21: 347-358.PubMed
23.
go back to reference Cooke BD, Fenner F: Rabbit haemorrhagic disease and the biological control of wild rabbits, Oryctolagus cuniculus, in Australia and New Zealand. Wildl Res. 2002, 29: 689-706. 10.1071/WR02010.CrossRef Cooke BD, Fenner F: Rabbit haemorrhagic disease and the biological control of wild rabbits, Oryctolagus cuniculus, in Australia and New Zealand. Wildl Res. 2002, 29: 689-706. 10.1071/WR02010.CrossRef
24.
go back to reference Capucci L, Scicluna MT, Lavazza A: Diagnosis of viral haemorrhagic disease of rabbits and the European brown hare syndrome. Rev Sci Tech. 1991, 10: 347-370.PubMed Capucci L, Scicluna MT, Lavazza A: Diagnosis of viral haemorrhagic disease of rabbits and the European brown hare syndrome. Rev Sci Tech. 1991, 10: 347-370.PubMed
25.
go back to reference Liu J, Kerr PJ, Wright JD, Strive T: Serological assays to discriminate rabbit haemorrhagic disease virus from Australian non-pathogenic rabbit calicivirus. Vet Microbiol. 2012, 157: 345-354. 10.1016/j.vetmic.2012.01.018.PubMedCrossRef Liu J, Kerr PJ, Wright JD, Strive T: Serological assays to discriminate rabbit haemorrhagic disease virus from Australian non-pathogenic rabbit calicivirus. Vet Microbiol. 2012, 157: 345-354. 10.1016/j.vetmic.2012.01.018.PubMedCrossRef
Metadata
Title
A sensitive and specific blocking ELISA for the detection of rabbit calicivirus RCV-A1 antibodies
Authors
June Liu
Peter J Kerr
Tanja Strive
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2012
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-9-182

Other articles of this Issue 1/2012

Virology Journal 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.